Finemedix파인메딕스
387570 · KOSDAQ · ₩387570 · 파인메딕스
₩5,860▼ ₩50 (0.85%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩9.5B | ₩10B |
| Cost of sales | ₩4.9B | ₩4.3B |
| Gross profit | ₩4.6B | ₩5.7B |
| Operating income | −₩2.6B | −₩29M |
| Net income | −₩1.9B | −₩24M |
| Net income to shareholders | −₩1.9B | −₩24M |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩26B | ₩27B |
| Current assets | ₩14B | ₩17B |
| Cash and equivalents | ₩3.1B | ₩10B |
| Total liabilities | ₩6.5B | ₩6.1B |
| Current liabilities | ₩2.7B | ₩3.1B |
| Borrowings | ₩3.5B | ₩3.5B |
| Total equity | ₩19B | ₩21B |
| Shareholders' equity | ₩19B | ₩21B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | −₩2.6B | ₩171M |
| Capital spending | ₩852M | ₩595M |
| Free cash flow | −₩3.5B | −₩425M |
Consolidated where available. Amounts in won.
Also known as: Finemedix / 파인메딕스 / 387570 / KRX:387570
Source: KRX statistical information